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In the past two decades, there has been a substantial
increase in the attention paid to patient-reported
outcomes (PROs) in health-care research and clini-
cal practice. Patient satisfaction, in particular, is
increasingly the focus of research and evaluation of
medical treatments, services, and interventions. A
crude PubMed title search for “satisfaction” (over
the past 20 years) revealed 6728 articles, almost
half of which have been published since 2000
[Fig. 1]. This increase in the number of publications
focusing on patient satisfaction (excluding those
studies where satisfaction may be one of several end
points) parallels the rise of “the patient as an active
consumer of health-care services rather than merely
as a passive recipient” [1].
It is signiﬁcant then that this is the ﬁrst issue of
Value in Health (a journal specializing in the eval-
uation of medical technologies) to be devoted to the
measurement of “patient satisfaction.” Satisfaction
is used increasingly as an end point in clinical trials
of new medications, particularly where two treat-
ments may be equivalent in their biomedical effects
but may differ substantially in terms of the patient’s
experience, for example, side effects, complexity of
administration, convenience. Patient satisfaction is
also important as a proxy measure or indicator of
future adherence to a given treatment; patients are
unlikely to continue with a treatment regimen that
they perceive to be ineffective, associated with
unpleasant side effects and/or encroaching on their
lifestyle [2].
Despite widespread use of the term, numerous
questionnaires designed to measure the concept,
and several thousand studies, very few published
articles have been concerned with deﬁning “patient
satisfaction” or providing any conceptual model to
inform its measurement. In an early review, Locker
and Dunt indicated that “. . . it is rare to ﬁnd the
concept of patient satisfaction deﬁned and there has
been little clariﬁcation of what the term means
either to the researchers who employ it or respond-
ents who respond to it” [3]. Unfortunately, patient
satisfaction remains an ill-deﬁned concept but there
have been attempts more recently to remedy this.
Patient satisfaction can be described as:
• “the extent of an individual’s experience com-
pared with his or her expectations” [4];
• “the patient’s evaluation of the process of tak-
ing the medication and the outcomes associated
with the medication” [1].
Implicit in these deﬁnitions is the assumption
that the patient attaches values to speciﬁc attributes
of the treatment or service, and that these are
unique to each individual’s experience.
The measurement of patient satisfaction has a
range of applications and is important in a variety
of clinical contexts. Shikiar and Rentz have pro-
posed a three-level hierarchy of satisfaction [1],
which includes:
1. satisfaction with health-care delivery (i.e., the
clinic or service, including issues of accessibil-
ity, clinician-patient communication, quality of
facilities);
2. satisfaction with treatment (i.e., with medica-
tion and other aspects of the treatment, e.g.,
dietary and exercise recommendations); and
3. satisfaction with medication (i.e., focusing on
the medication per se, rather than the broader
treatment experience).
Generic, condition-speciﬁc, and medication-
speciﬁc measures provide great choice in their level
of assessment and speciﬁcity. Generic measures have
the beneﬁt of allowing the opportunity for compar-
ison across conditions. In particular, they have the
advantage of enabling use of a well-validated meas-
ure in an unusual disease for which a validated con-
dition-speciﬁc measure may not yet be available.
Condition-speciﬁc measures have the beneﬁt of
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focusing on the particular characteristics of the dis-
ease, while enabling the respondent to take into
account all aspects of his/her treatment. In addition,
they allow researchers to compare the characteris-
tics of one treatment with those of another for the
same condition (e.g., tablets vs. injections). Medica-
tion-speciﬁc measures focus on speciﬁc attributes
(e.g., inhaled administration of insulin) but do not
necessarily allow comparison with other forms of
the same treatment (e.g., injection of insulin).
There are multiple methods available for assess-
ing patient satisfaction. Whereas interview-based
measures and multi-item questionnaires provide
detail for a rigorous research study, single-item
measures offer simplicity and speed for the pur-
poses of clinical audit, and reduce patient burden
when several other PROs need to be measured.
Nevertheless, single-item measures are often met
with skepticism, as their psychometric properties
have rarely been established. Multi-item measures
vary hugely in their focus and content. They can
include:
• several items that contribute to one overall rat-
ing of satisfaction;
• several subscales measuring the different
dimensions of satisfaction (e.g., efﬁcacy, side
effects, convenience);
• items relating only to treatment outcomes;
• items relating to the experience (process) as
well as outcomes;
• items that relate to the prediction of satisfaction
(e.g., expectations); and
• items that relate to the consequences of satis-
faction (e.g., willingness to continue).
The articles in this supplement of Value in
Health detail the measurement of patient satisfac-
tion in a variety of ways and illustrate a range of
applications:
Hareendran and Abraham’s article provides an
innovative account of the application of patient sat-
isfaction in the development of a new medication
for benign prostatic hyperplasia. Their use of a
multi-item condition-speciﬁc measure is important
in obtaining the level of detail needed to inform
decisions about optimum doses to be included in
future trials.
By contrast, Andreas Pleil and colleagues have
used a generic instrument including single items to
measure beneﬁts, satisfaction, and willingness to
continue (BSW) in a group of patients with overac-
tive bladder. They provide evidence of the measures’
construct and discriminant validity and argue that
“single-item measures have the advantage of brev-
ity, ease of administration and ease of interpreta-
tion.” Although the former are indisputable and
highly desirable attributes, the latter is more con-
tentious. We have no guarantee that the respond-
ents are considering all aspects of the treatment
when making their rating. This is particularly the
case when considering “satisfaction” and “willing-
ness to continue,” which may be unduly inﬂuenced
by the “beneﬁts” already rated, with little or no
consideration of other treatment attributes such as
side effects or convenience.
The validation of the generic multi-item Treat-
ment Satisfaction Questionnaire for Medication
(version II) (TSQM-II), among outpatient pharmacy
consumers, highlights yet another useful application
of satisfaction measures. In this article, Atkinson
and colleagues focus on satisfaction with medica-
tion (as opposed to treatment or service) and pro-
vide an interesting conceptual framework for the
development of their measure. Furthermore, they
focus on the measurement of medication attributes,
excluding determinants and consequences of satis-
faction, such as expectations and willingness to con-
tinue, respectively. While acknowledging that theirs
Figure 1 Increasing number of PubMed
publications with “satisfaction” in the title.
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is not a universally accepted approach, they provide
a persuasive argument and propose a decisional-
balance model for the rating of patient satisfaction.
Linda Abetz and colleagues report on the design
of a new instrument, the Cancer Therapy Satisfac-
tion Questionnaire, which describes the detailed
qualitative phase of item generation and develop-
ment. Their discovery in a later round of cognitive
debrieﬁng interviews that the word “chemother-
apy” implies intravenous (IV) treatment to those
receiving tablets highlights the importance of the
qualitative process in questionnaire design. If they
had not identiﬁed this problem with wording, their
questionnaire may have been applicable only to
those receiving IV treatment, whereas now it is suit-
able for comparing IV (hospital-based) and tablet
(home-based) treatment in a range of cancers.
Finally, Joseph Cappelleri and colleagues have
investigated the relationship between satisfaction
and self-esteem in men with erectile dysfunction
(ED). Their article highlights the importance of con-
sidering satisfaction in the wider context of other
psychosocial outcomes of importance to the patient.
Satisfaction does not operate in a vacuum but few
articles have investigated the relationship between
satisfaction and other outcomes, such as well-being
or quality of life. Cappelleri and colleagues argue
for the importance of measuring the impact of ED
treatment on self-esteem, conﬁdence, and relation-
ships as well as on satisfaction.
This supplement serves as a reminder that that
there is no gold standard when it comes to measur-
ing patient satisfaction. Concepts, applications,
and measurement are varied. The wide variety of
instruments used to measure patient satisfaction is
both an advantage and an obstacle in promoting
the inclusion of the patient’s perspective. It is
hoped that this supplement will stimulate discus-
sion of some of the problems that have yet to be
resolved and the opportunities available to further
our understanding of “patient satisfaction.”
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